NEIL2 and cancer: Since NEIL1, NEIL2, and NEIL3 have been experimentally shown to have the ability to suppress mutations in human cells and/or in bacterial cells [9–12], the finding that the reductions in NEIL1 and NEIL2 expression were associated with the increase in the number of somatic mutations in cancer seems reasonable.